Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl C Ward

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
ACS Chemical Biology|April 27, 2017
NHS-Esters As Versatile Reactivity-Based Probes for Mapping Proteome-Wide Ligandable HotspotsCarl C Ward, Jordan I Kleinman, Daniel K Nomura
Biochemistry|September 2, 2021
Ligandability of E3 Ligases for Targeted Protein Degradation ApplicationsBridget P Belcher, Carl C Ward, Daniel K Nomura
Current Opinion in Biotechnology|August 30, 2016
Activity-based protein profiling for mapping and pharmacologically interrogating proteome-wide ligandable hotspotsAllison M Roberts, Carl C Ward, Daniel K Nomura
Journal of Proteome Research|February 5, 2014
Discovery of human sORF-encoded polypeptides (SEPs) in cell lines and tissueJiao Ma, Carl C Ward, Irwin Jungreis, et al.
Nature Chemical Biology|July 10, 2019
Covalent targeting of the vacuolar H<sup>+</sup>-ATPase activates autophagy via mTORC1 inhibitionClive Yik-Sham Chung, Hijai R Shin, Charles A Berdan, et al.
Cell Chemical Biology|September 19, 2017
Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural ProductsElizabeth A Grossman, Carl C Ward, Jessica N Spradlin, et al.
Cell Chemical Biology|January 29, 2019
Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell StateLeslie Magtanong, Pin-Joe Ko, Milton To, et al.
ACS Chemical Biology|May 7, 2019
Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation ApplicationsCarl C Ward, Jordan I Kleinman, Scott M Brittain, et al.
Nature|April 3, 2024
Improving prime editing with an endogenous small RNA-binding proteinJun Yan, Paul Oyler-Castrillo, Purnima Ravisankar, et al.
Nature Chemical Biology|June 19, 2019
Harnessing the anti-cancer natural product nimbolide for targeted protein degradationJessica N Spradlin, Xirui Hu, Carl C Ward, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
ACS Chemical Biology|April 27, 2017
NHS-Esters As Versatile Reactivity-Based Probes for Mapping Proteome-Wide Ligandable HotspotsCarl C Ward, Jordan I Kleinman, Daniel K Nomura
Biochemistry|September 2, 2021
Ligandability of E3 Ligases for Targeted Protein Degradation ApplicationsBridget P Belcher, Carl C Ward, Daniel K Nomura
Current Opinion in Biotechnology|August 30, 2016
Activity-based protein profiling for mapping and pharmacologically interrogating proteome-wide ligandable hotspotsAllison M Roberts, Carl C Ward, Daniel K Nomura
Journal of Proteome Research|February 5, 2014
Discovery of human sORF-encoded polypeptides (SEPs) in cell lines and tissueJiao Ma, Carl C Ward, Irwin Jungreis, et al.
Nature Chemical Biology|July 10, 2019
Covalent targeting of the vacuolar H<sup>+</sup>-ATPase activates autophagy via mTORC1 inhibitionClive Yik-Sham Chung, Hijai R Shin, Charles A Berdan, et al.
Cell Chemical Biology|September 19, 2017
Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural ProductsElizabeth A Grossman, Carl C Ward, Jessica N Spradlin, et al.
Cell Chemical Biology|January 29, 2019
Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell StateLeslie Magtanong, Pin-Joe Ko, Milton To, et al.
ACS Chemical Biology|May 7, 2019
Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation ApplicationsCarl C Ward, Jordan I Kleinman, Scott M Brittain, et al.
Nature|April 3, 2024
Improving prime editing with an endogenous small RNA-binding proteinJun Yan, Paul Oyler-Castrillo, Purnima Ravisankar, et al.
Nature Chemical Biology|June 19, 2019
Harnessing the anti-cancer natural product nimbolide for targeted protein degradationJessica N Spradlin, Xirui Hu, Carl C Ward, et al.
Pageof 2